Quick summary:
- G9 PCa Dx in 2016: RP and adjuvant radiation and ADT therapy.
- 2018 biochemical recurrence with 6 week PSA doubling time.
- Participated in Condor Trial. PSMA scan located recurrence in a handful of LNs. Treated with RT and 20 months of ADT/abiraterone/prednisone.
- Undetectable (<0.02) PSA for 33 months...until this month. Reconfirmed 2 weeks later when the PSA tripled to 0.06.
I was disappointed, but not surprised that I've had another recurrence. My hope was that the PCa had not progressed any further than the pelvic area LNs that were detected by the 18F-DCFPyL-PET/CT, but apparently it had. Now what? I have an appointment with my local MO in two weeks to get his opinion. I assume the choices are immediate systemic treatment (ADT, perhaps in combo with abiraterone again...or something else?) or waiting until the recurrence is detectable on the recently approved PSMA scans. How high would my PSA need to rise in order for the PSMA scans to have a likelihood of detection? I'm leaning to that approach to at least see where the PCa is before (presumably) repressing it with ADT+.